Ads
related to: what is the fda
Search results
FDA panel votes against ecstasy for PTSD
Axios· 11 hours agoWhy it matters: While there's a growing effort to use hallucinogenic substances as behavioral health treatments, regulators are grappling with how to...
The FDA should stop letting drug companies skip steps - The Boston Globe
The Boston Globe· 1 day agoThe FDA approves some new medical treatments quickly, before confirmatory trials are carried out, to...
FDA advisers consider MDMA therapy to treat PTSD
WKOW 27 Madison· 21 hours agoIt’s the first time the FDA’s advisers have considered a psychedelic drug for medical use. The novel treatment has the potential to transform a field...
MDMA Treatment for PTSD Gets Voted Against by FDA Advisers
TMZ· 10 hours ago4:22 PM PT -- And just like that, the FDA advisers who were mulling over using ecstasy to treat...
FDA vaccine advisors expected to vote on new COVID-19 booster formula
ABC Action News Tampa Bay· 19 hours agoThe FDA’s vaccine advisory committee is expected to meet Tuesday. It was postponed due to the...
FDA panel to evaluate psychedelic MDMA for treatment of PTSD for first time
Fox News· 18 hours agoA panel of advisers to the U.S. Food and Drug Administration will meet to discuss a therapy based on...
Denali, Neurogene and more picked by FDA's 'Operation Warp Speed' for rare disease
FierceBiotech· 14 hours agoThe FDA’s “Operation Warp Speed” equivalent for rare disease will include programs from Denali...
FDA advisers consider MDMA therapy to treat PTSD
WKBT La Crosse· 15 hours agoClick here to view this video from News8000.com.
FDA advisory panel votes against allowing MDMA as PTSD treatment
UPI· 7 hours agoThe popular underground drug midomafetamine, also called MDMA and "ecstasy," failed to win an...
FDA panel rejects first MDMA treatment amid deep concerns about flawed trials
AOL· 10 hours agoThe two votes — one for the treatment’s efficacy and one for its safety, by the agency’s Psychopharmacologic Drugs Advisory Committee — marked the first time that FDA advisers ...
